Provided by Tiger Trade Technology Pte. Ltd.

VolitionRX

0.2821
+0.00722.62%
Volume:26.18M
Turnover:7.38M
Market Cap:7.87M
PE:-0.07
High:0.2951
Open:0.2900
Low:0.2729
Close:0.2749
52wk High:14.80
52wk Low:0.2729
Shares:27.90M
Float Shares:26.23M
Volume Ratio:24.93
T/O Rate:99.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8023
EPS(LYR):-4.3726
ROE:-730.06%
ROA:-142.94%
PB:-0.24
PE(LYR):-0.06

Loading ...

VolitionRX - Seeks Partners for Field Trials and Deployment of Lft Prototypes in Outbreak Zones

THOMSON REUTERS
·
Jun 03

VolitionRX Files New Patent Protecting Its Nu.q® Nets Test for Ebola Triage and Treatment Monitoring

THOMSON REUTERS
·
Jun 03

VolitionRx posts corporate deck outlining Nu.Q licensing strategy across cancer, sepsis and veterinary testing

Reuters
·
May 28

VolitionRx posts $1 million Q1 revenue, up 300% year over year

Reuters
·
May 27

VolitionRx submits peer-reviewed study of Nu.Q Vet feline lymphoma blood test, eyes $5 million milestone

Reuters
·
May 27

VolitionRx waives Lind note covenant breach, triggers 10% step-up charge

Reuters
·
May 23

VolitionRX Earnings Call Balances Breakthroughs and Risks

TIPRANKS
·
May 20

VolitionRX Earnings Call: Breakthrough Science, Cash Burn Risk

TIPRANKS
·
May 16

VolitionRx director Mickie Henshall steps down, won’t seek re-election

Reuters
·
May 16

VolitionRx publishes corporate deck outlining Nu.Q licensing strategy in cancer, sepsis diagnostics

Reuters
·
May 15

BRIEF-VolitionRX Limited Announces First Quarter 2026 Financial Results

Reuters
·
May 15

VolitionRX Q1 EPS $(0.97) Misses $(0.75) Estimate, Sales $985.076K Beat $426.600K Estimate

Benzinga Earnings
·
May 15

VolitionRX Q1 FY26 net loss widens 22% to $6.7 million; revenue more than doubles to $1 million

Reuters
·
May 15

VolitionRx schedules first-quarter earnings conference call and business update

Reuters
·
May 11

Press Release: VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update

Dow Jones
·
May 11

VolitionRx feline cancer blood test study shows 86% sensitivity at 97% specificity

Reuters
·
May 06

VolitionRX Announces Submission of Manuscript for Nu.q® Vet Cancer Test in Cats

THOMSON REUTERS
·
May 06

VolitionRx detects nucleosomes in sepsis patients using finger-prick lateral flow prototype study

Reuters
·
Apr 29

VolitionRx enacts 1-for-20 reverse stock split via charter amendment

Reuters
·
Apr 29

VolitionRx wins NYSE American approval of compliance plan, avoids immediate delisting

Reuters
·
Apr 23